Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer

Research output: Contribution to journalArticleScientificpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)e522-e533
JournalCLINICAL BREAST CANCER
Volume19
Issue number4
DOIs
Publication statusPublished - 2019
Publication typeA1 Journal article-refereed

Keywords

  • Bevacizumab
  • First-line chemotherapy treatment
  • Interleukin 8
  • Metastatic breast cancer
  • Prognosis

Publication forum classification

  • Publication forum level 1

Cite this